QuellTX
Laura Fry has extensive work experience in the field of cell processing and advanced therapy production. Laura currently holds the position of Head of Cell Processing at Quell Therapeutics since July 2019. Prior to this, they worked at Guy's and St Thomas' NHS Foundation Trust where they held the roles of Head of Advanced Therapy Production from September 2017 to December 2019, and Senior Immune Therapy Production Scientist from April 2015 to September 2017. Before joining the NHS, Laura worked as a GMP Production Scientist at the University of Oxford from March 2014 to April 2015. Laura also gained experience at Anthony Nolan as a PhD Student from March 2010 to February 2014 and as a Laboratory Scientist from January 2008 to July 2013. Laura's early work experience includes a role as a Laboratory Technician at LGC Forensics from August 2007 to December 2007.
Laura Fry attended the University of Nottingham from 2003 to 2007, where they obtained an MSci degree in Biochemistry and Biological Chemistry.
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.